Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
ACQUIRED COMPANY
 
My Lists

Proteolix  Acquired by Onyx Pharmaceuticals (2009 $ 276,000,000 )

333 Allerton Avenue
South San Francisco, CA 94080
USA
650.266.2600
Website Company Summary Management Team
Company

Business description: Proteolix develops inhibitors of proteasome-medicated protein degradation in cells. Proteolix is dedicated to becoming the premier biopharmaceutical experts in this field developing novel inhibitors that regulate protein turnover for the treatment of important human diseases. Proteolix is also developing, in parallel, a strong internal program of research and pre-clinical development, and is focused on moving therapeutic agents into the clinic as quickly as possible.
Capital

Rounds: 4
Recent Fundings: Dec 2014   Sep 2008
Capital raised: 147.3M
Last Round: 5.0M
Ownership: Acquired by Onyx Pharmaceuticals (2009 $ 276,000,000 )
VCs include: Advanced Technology VenturesDelphi VenturesU.S. Venture PartnersThe Vertical Group;  Nomura Phase4 Ventures;  Latterell Venture Partners;  Westfield Capital Management
Corporate investors: Genentech

Last Tweets


 

Last Mentions


Overview
Record updated: Oct 2009
Sector: Biotech
Rounds: 4
Recent Fundings: Dec 2014   Sep 2008
Capital Raised: 147.3M
Last Round: 5.0M
Ownership: Acquired by Onyx Pharmaceuticals (2009 $ 276,000,000 )